Hypertonicity induction of melanoma antigen, a tumor-associated antigen

Molecules and Cells

Volumn 13, Issue 2, 2002, Pages 288-295

  Park, Joo Hung ^a   Lee, Soo Woong ^a  

^a Changwon National University   (South Korea)

Author keywords

MAGE; NaCl; Tumor associated antigen

Indexed keywords

DINUCLEOTIDE; HYPERTONIC SOLUTION; MELANOMA ANTIGEN; MESSENGER RNA; SODIUM CHLORIDE; TRANSCRIPTION FACTOR; 5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC ANTIMETABOLITE; AZACITIDINE; DACTINOMYCIN; DRUG DERIVATIVE; MAGEA1 PROTEIN, HUMAN; MAGEB2 PROTEIN, HUMAN; PROTEIN SYNTHESIS INHIBITOR; TUMOR ANTIGEN; TUMOR PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CPG ISLAND; DEMETHYLATION; GENE EXPRESSION; RNA STABILITY; TRANSCRIPTION INITIATION; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; UPREGULATION;

ANTIGENS, NEOPLASM; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; DACTINOMYCIN; GENE EXPRESSION REGULATION; HUMANS; HYPERTONIC SOLUTIONS; NEOPLASM PROTEINS; PROTEIN SYNTHESIS INHIBITORS; RNA STABILITY; SODIUM CHLORIDE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037198114     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Becker, J. C., Gillitzer, R., and Brocker, E.-B. (1994) A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int. J. Cancer 58, 346-348.
2. Bituon, M. and Tappaz, M. (2000) Gene expression of the transporters and biosynthetic enzymes of the osmolytes in astrocyte primary cultures exposed to hyperosmotic conditions. GLIA 32, 165-176.
3. Chen, W. Y., Bailey, E. C., McCune, S. L., Dong, J.-Y., and Townes, T. M. (1997) Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc. Natl. Acad. Sci. USA 94, 5798-5803.
4. Dabovic, B., Zanaria, E., Bardoni, B., Lisa, A., Bordignon, C., Russo, V., Matessi, C., Traversari, C., and Camerino, G. (1995) A family of rapidly evolving genes from the sex reversal critical region in Xp21. Mamm. Genome 6, 571-580.
5. De Backer, O., Verheyden, A.-M., Martin, B., Godelaine, D., De Olaen, E., Brasseur, R., Avner, P., and Boon, T. (1995) Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes. Genomics 28, 74-83.
6. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J.-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethe, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40, 360-369.
7. De Plaen, E., De Backer, O., Arnaud, D., Bonjean, B., Chomez, P., Martelange, V., Avner, P., Baldacci, P., Babinet, C., Hwang, S.-Y., Knowles, B., and Boon, T. (1999) A new family of mouse genes homologous to the human MAGE genes. Genomics 55, 176-184.
8. De Smet, C., Courtois, S. J., Faraoni, I., Lurquin, C., Szikora, J.-P., De Backer, O., and Boon, T. (1995) Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics 42, 282-290.
9. De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., and Boon, T. (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA 93, 7149-7153.
10. De Smet, C., Lurquin, C., Lethe, B., Martelange, V., and Boon, T. (1999) DNA methylation in the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19, 7327-7335.
11. Forslund, K. O. and Nordqvist, K. (2001) The melanoma antigen genes-any clues to their functions in normal tissues? Exp. Cell Res. 265, 185-194.
12. Garry, R., Moyer, M., Bishop, J., Moyer, R., and Waite, M. (1981) Transformation parameters induced in chick cells by incubation in media of altered NaCl concentration. Virology 111, 427-439.
13. Gatsios, P., Terstegen, L., Schliess, F., Haussinger, D., Kerr, I. M., Heinrich, P. C., Graeve, L. (1998) Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock. J. Biol. Cliem. 273, 22962-22968.
14. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921-930.
15. Gillespie, A. M., Rodgers, S., Wilson, A. P., Tidy, J., Rees, R. C., Coleman, R. E., and Murray, A. K. (1998) MAGE, BAGE and GAGE: tumor antigen expression in benign and malignant ovarian tissue. Br. J. Cancer 78, 816-821.
16. Groudine, M. and Weintraub, H. (1982) Propagation of globin DNAase I-hypersensitive sites in absence of factors required for induction: a possible mechanism for determination. Cell 30, 131-139.
17. Hayashi, Y., Matsuyama, K., Takagi, K., Sugiura, H., and Yoshikawa, K. (1995) Arrest of cell growth by necdin, a nuclear protein expressed in postmitotic neurons. Biochem. Biophys. Res. Commun. 213, 317-324.
18. Hoon, D. S. B., Yuzuki, D., Hayashida, M., and Morton, D. L. (1995) Melanoma patients immunized with cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J. Immunol. 154, 730-737.
19. Houghton, A. N. (1994) Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180, 1-4.
20. Kocher, T., Schultz-Thater, E., Gudat, F., Schaefer, C., Casorati, G., Juretic, A., Willimann, T., Harder, F., Heberer, M., and Spagnoli, G. C. (1995) Identification and intracellular location of MAGE-3 gene product. Cancer Res. 55, 2236-2239.
21. Landry, C., Brasseur, F., Spagnoli, G. C., Marbaix, E., Boon, T., Coulie, P., and Godelaine, D. (2000) Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int. J. Cancer 86, 835-841.
22. Lee, J.-H. (2001) Production of tumor associated antigen MAGE protein, development and function of monoclonal antibody. M.S. Thesis, Changwon National University, Changwon, Korea.
23. Lee, J.-H., Sung, B.-H., Youn, H.-J., and Park, J.-H. (2000) Identification, expression, and nuclear location of murine Mage-b2 protein, a tumor-associated antigen. Mol. Cells 10, 647-653.
24. Lucas, S., De Smet, C., Arden, K. C., Viars, C. S., Lethe, B., Lurquin, C., and Boon, T. (1998) Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res. 58, 743-752.
25. Lucas, S., Brasseur, F., and Boon, T. (1999) A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells. Cancer Res. 59, 4100-4103.
26. Lurquin, C., De Smet, C., Brasseur, F., Muscatelli, F., Martelange, V., De Plaen, E., Brasseur, R., Monaco, A. P., and Boon, T. (1997) Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46, 397-408.
27. Maeurer, M. J., Storkus, W. J., Kirkwood, J. M., and Lotze, M. T. (1996) New treatment options for patients with melanoma: review of melanoma-derived T-cell epitopc-based peptide vaccines. Melanoma Res. 6, 11-24.
28. Maruyama, K., Usami, M., Aizawa, T., and Yoshikawa, K. (1991) A novel brain-specific mRNA encoding nuclear protein (necdin) expressed in neurally differentiated embryomal carcinoma cells. Biochem. Biophys. Res. Commun. 178, 291-296.
29. Miyakawa, H., Woo, S. K., Dahl, S. C., Handler, J. S., and Kwon, K. M. (1999) Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl. Acad. Sci. USA 96, 2538-2542.
30. Muscatelli, F., Walker, A. P., De Plaen, E., Stafford, A. N., and Monaco, A. P. (1995) Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc. Natl. Acad. Sci. USA 92, 4987-4991.
31. Osterlund, C., Tobonen, V., Forslund, O. K., and Nordqvist, K. (2000) Mage-b4, a novel melanoma antigen (MAGE) gene specifically expressed during germ cell differentiation. Cancer Res. 60, 1054-1061.
32. Park, J.-H., Kim, C.-J., Lee, J.-H., Shin, S.-H., Chung, G.-H., and Jang, Y.-S. (1999) Effective immunotherapy of cancer by DNA vaccination. Mol. Cells 9, 384-391.
33. Pold, M., Zhou, J., Chen, G. L., Hall, J. M., Vescio, R. A., and Berenson, J. R. (1999) Identification of a new, unorthodox member of the MAGE gene family. Genomics 59, 161-167.
34. Salnikow, K., Su, W., Blagosklonny, M. V., and Costa, M. (2000) Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res. 60, 3375-3378.
35. Stone, B., Schummer, M., Paley, P. J., Crawford, M., Ford, M., Urban, N., and Nelson, B. H. (2001) MAGE-F1, a novel ubiquitously expressed member of the MAGE family. Gene 267, 173-182.
36. Suzuki, K., Tsujitani, S., Kinishi, I., Yamaguchi, Y., Hirooka, Y., and Kaibara, N. (1999) Expression of MAGE genes and survival in patients with hepatocellular carcinoma. Int. J. Oncol. 15, 1227-1232.
37. Takahashi, K., Shichijo, S., Noguchi, M., Hirohata, M., and Itoh, K. (1995) Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. 55, 3478-3482.
38. Taniura, H., Taniguchi, N., Hara, M., and Yoshikawa, K. (1998) Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J. Biol. Chem. 273, 720-728.
39. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., van den Eynde, B., Knuth, A., and Boon, T. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.
40. Weber, J. S., Hua, F. L., Spears, L., Marty, V., Kuniyoshi, C., and Celis, E. (1999) A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma. J. Immunother. 22, 431-440.
41. Woo, S. K., Nahm, O., and Kwon, H. M. (2000) How salt regulates genes: function of a Rel-like transcription factor TonEBP. Biochem. Biophys. Res. Commun. 278, 269-271.
42. Yancey, P. H., Clark, M. E., Hand, S. E., Bowlus, R. D., and Somero, G. N. (1982) Living with water stress: evolution of osmolyte systems. Science 217, 1214-1222.